UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 726

Sortiert nach

Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial

Annals of oncology, 2016-04, Vol.27 (4), p.619-624

2016

Link zum Volltext

Verfügbarkeit prüfen

Relationship between fluorodeoxyglucose uptake in the large vessels and late aortic diameter in giant cell arteritis

Rheumatology (Oxford, England), 2008-08, Vol.47 (8), p.1179-1184

2008

Link zum Volltext

Verfügbarkeit prüfen

To PET or not to PET: what are the indications?

European journal of cancer (1990), 2011-09, Vol.47, p.S304-S305

Stroobants, S

2011

Link zum Volltext

Verfügbarkeit prüfen

Preclinical molecular imaging of glutamatergic and dopaminergic neuroreceptor kinetics in obsessive compulsive disorder

Progress in neuro-psychopharmacology & biological psychiatry, 2017-07, Vol.77, p.90-98

2017

Link zum Volltext

Verfügbarkeit prüfen

Estimation of and correction for finite motion sampling errors in small animal PET rigid motion correction

Medical & biological engineering & computing, 2019-02, Vol.57 (2), p.505-518

2019

Link zum Volltext

Verfügbarkeit prüfen

Postnatal disruption of the disintegrin/metalloproteinase ADAM10 in brain causes epileptic seizures, learning deficits, altered spine morphology, and defective synaptic functions

The Journal of neuroscience, 2013-08, Vol.33 (32), p.12915-12928

2013

Link zum Volltext

Verfügbarkeit prüfen

3 speaker: Clinical Trial Prospective

Radiotherapy and oncology, 2010-03, Vol.94, p.S5-S5

Stroobants, S

2010

Link zum Volltext

Verfügbarkeit prüfen

Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration

The European respiratory journal, 2009-01, Vol.33 (1), p.201-212

2009

Link zum Volltext

Verfügbarkeit prüfen

Small-animal repetitive transcranial magnetic stimulation combined with [18 F]-FDG microPET to quantify the neuromodulation effect in the rat brain

Neuroscience, 2014-09, Vol.275, p.436-443

2014

Link zum Volltext

Verfügbarkeit prüfen

Using PET for therapy monitoring in oncological clinical trials: challenges ahead

European journal of nuclear medicine and molecular imaging, 2017-08, Vol.44 (Suppl 1), p.32-40

2017

Link zum Volltext

Verfügbarkeit prüfen

Utility of Positron Emission Tomography for the Staging of Patients With Potentially Operable Esophageal Carcinoma

Journal of clinical oncology, 2000-09, Vol.18 (18), p.3202-3210

2000

Link zum Volltext

Verfügbarkeit prüfen

Specific suppression of microgliosis cannot circumvent the severe neuropathology in peroxisomal β-oxidation-deficient mice

Molecular and cellular neuroscience, 2017-04, Vol.80, p.123-133

2017

Link zum Volltext

Verfügbarkeit prüfen

Aberrant patterns of PET response during treatment for DLBCL patients with MYC gene rearrangements

European journal of nuclear medicine and molecular imaging, 2022-02, Vol.49 (3), p.943-952

2022

Link zum Volltext

Verfügbarkeit prüfen

Additional value of PET-CT in the staging of lung cancer: comparison with CT alone, PET alone and visual correlation of PET and CT

European radiology, 2007-01, Vol.17 (1), p.23-32

2007

Link zum Volltext

Verfügbarkeit prüfen

Early restaging positron emission tomography with ( 18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma

Annals of oncology, 2002-09, Vol.13 (9), p.1356

2002

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Value of Positron Emission Tomography (PET) With Fluorine-18 Fluorodeoxyglucose ([18F]FDG) After First-Line Chemotherapy in Non-Hodgkin’s Lymphoma: Is [18F]FDG-PET a Valid Alternative to Conventional Diagnostic Methods?

Journal of clinical oncology, 2001-01, Vol.19 (2), p.414-419

2001

Link zum Volltext

Verfügbarkeit prüfen

Clinical Value of [18F]fluoro-Deoxyglucose Positron Emission Tomography for Patients with Fever of Unknown Origin

Clinical infectious diseases, 2001-01, Vol.32 (2), p.191-196

2001

Link zum Volltext

Verfügbarkeit prüfen

Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients

Journal of clinical oncology, 1998-06, Vol.16 (6), p.2142-2149

1998

Link zum Volltext

Verfügbarkeit prüfen

Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer

The European respiratory journal, 2007-05, Vol.29 (5), p.995-1002

2007

Link zum Volltext

Verfügbarkeit prüfen

Test–retest reliability of [18 F]PBR111 binding to translocator protein (TSPO) in young healthy control subjects

European neuropsychopharmacology, 2016-10, Vol.26, p.S214-S214

2016

Link zum Volltext

Verfügbarkeit prüfen

Simultaneous maximum a posteriori reconstruction of attenuation and activity distributions from emission sinograms

IEEE transactions on medical imaging, 1999-05, Vol.18 (5), p.393-403

1999

Link zum Volltext
Volltext

P.1.f.019 Methodological aspects of translocator protein positron emission tomography for microglial activation in schizophrenia patients

European neuropsychopharmacology, 2015-09, Vol.25, p.S234-S235

2015

Link zum Volltext

Verfügbarkeit prüfen

New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography

Rheumatology (Oxford, England), 1999-05, Vol.38 (5), p.444-447

1999

Link zum Volltext

Verfügbarkeit prüfen

Additional value of integrated PET-CT in the detection and characterization of lung metastases: correlation with CT alone and PET alone

European radiology, 2007-02, Vol.17 (2), p.467-473

2007

Link zum Volltext

Verfügbarkeit prüfen

The value of [ 18F]fluoro-2-deoxy- d-glucose positron emission tomography in the selection of patients with stage IIIA-N2 non-small cell lung cancer for combined modality treatment

Lung cancer (Amsterdam, Netherlands), 2003-02, Vol.39 (2), p.151-157

2003

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 726

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(645)
Mit Volltextzugriff
(660)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(354)
Life Sciences & Biomedicine
(303)
Humans
(236)
Female
(131)
Male
(123)
Animals
(103)
Biological And Medical Sciences
(89)
Middle Aged
(81)
Medical Sciences
(79)
Positron Emission Tomography
(76)
Radiology, Nuclear Medicine & Medical Imaging
(71)
Fluorodeoxyglucose F18
(69)
Aged
(67)
Oncology
(67)
Adult
(63)
Mice
(62)
Radiopharmaceuticals
(57)
Positron-Emission Tomography
(50)
Physical Sciences
(49)
Tomography
(47)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial

Relationship between fluorodeoxyglucose uptake in the large vessels and late aortic diameter in giant cell arteritis

To PET or not to PET: what are the indications?

Preclinical molecular imaging of glutamatergic and dopaminergic neuroreceptor kinetics in obsessive compulsive disorder

Estimation of and correction for finite motion sampling errors in small animal PET rigid motion correction

Postnatal disruption of the disintegrin/metalloproteinase ADAM10 in brain causes epileptic seizures, learning deficits, altered spine morphology, and defective synaptic functions

3 speaker: Clinical Trial Prospective

Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration

Small-animal repetitive transcranial magnetic stimulation combined with [18 F]-FDG microPET to quantify the neuromodulation effect in the rat brain

Using PET for therapy monitoring in oncological clinical trials: challenges ahead

Utility of Positron Emission Tomography for the Staging of Patients With Potentially Operable Esophageal Carcinoma

Specific suppression of microgliosis cannot circumvent the severe neuropathology in peroxisomal β-oxidation-deficient mice

Aberrant patterns of PET response during treatment for DLBCL patients with MYC gene rearrangements

Additional value of PET-CT in the staging of lung cancer: comparison with CT alone, PET alone and visual correlation of PET and CT

Early restaging positron emission tomography with ( 18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma

Prognostic Value of Positron Emission Tomography (PET) With Fluorine-18 Fluorodeoxyglucose ([18F]FDG) After First-Line Chemotherapy in Non-Hodgkin’s Lymphoma: Is [18F]FDG-PET a Valid Alternative to Conventional Diagnostic Methods?

Clinical Value of [18F]fluoro-Deoxyglucose Positron Emission Tomography for Patients with Fever of Unknown Origin

Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients

Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer

Test–retest reliability of [18 F]PBR111 binding to translocator protein (TSPO) in young healthy control subjects

Simultaneous maximum a posteriori reconstruction of attenuation and activity distributions from emission sinograms

P.1.f.019 Methodological aspects of translocator protein positron emission tomography for microglial activation in schizophrenia patients

New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography

Additional value of integrated PET-CT in the detection and characterization of lung metastases: correlation with CT alone and PET alone

The value of [ 18F]fluoro-2-deoxy- d-glucose positron emission tomography in the selection of patients with stage IIIA-N2 non-small cell lung cancer for combined modality treatment

Suchergebnisse filtern